News

Regulatory affairsRegulatory Round-up - January 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Regulatory Round-up - June 2024Regulatory Round-up - June 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesPlurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesRegulatory Round-up - May 2024Regulatory Round-up - May 2024CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesRegulatory Round-up - April 2024Regulatory Round-up - April 2024Jim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsRegulatory Round-up - March 2024Regulatory Round-up - March 2024Standing out: Defining the market for your new ATMP assetStanding out: Defining the market for your new ATMP asset